Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation

被引:79
作者
Gonzales, MJ
Delwart, E
Rhee, SY
Tsui, R
Zolopa, AR
Taylor, J
Shafer, RW
机构
[1] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Stat, Stanford, CA 94305 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
关键词
D O I
10.1086/376534
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We examined consecutive protease (PR) and reverse transcriptase (RT) sequences from human immunodeficiency virus (HIV) type 1-infected individuals, to distinguish changes resulting from sequence evolution due to possible superinfection. Between July 1997 and December 2001, greater than or equal to2 PR and RT samples from 718 persons were sequenced at Stanford University Hospital. Thirty-seven persons had highly divergent sequence pairs characterized by a nucleotide distance of >4.5% in PR or >3.0% in RT. In 16 of 37 sequence pairs, divergence resulted from the loss of mutations during a treatment interruption or from the gain of mutations with reinstitution of treatment. tat and/or gag sequencing of HIV-1 from cryopreserved plasma samples could be performed on 15 of the 21 divergent isolate pairs from persons without a treatment interruption. The sequences of these genes, unaffected by selective drug pressure, were monophyletic. Although HIV-1 PR and RT genes from treated persons may become highly divergent, these changes usually are the result of sequence evolution, rather than superinfection.
引用
收藏
页码:397 / 405
页数:9
相关论文
共 24 条
  • [1] HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus
    Altfeld, M
    Allen, TM
    Yu, XG
    Johnston, MN
    Agrawal, D
    Korber, BT
    Montefiori, DC
    O'Connor, DH
    Davis, BT
    Lee, PK
    Maier, EL
    Harlow, J
    Goulder, PJR
    Brander, C
    Rosenberg, ES
    Walker, BD
    [J]. NATURE, 2002, 420 (6914) : 434 - 439
  • [2] [Anonymous], HIV AIDS EP ANN REP
  • [3] Human immunodeficiency virus superinfection and recombination: Current state of knowledge and potential clinical consequences
    Blackard, JT
    Cohen, DE
    Mayer, KH
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (08) : 1108 - 1114
  • [4] Devereux HL, 1999, AIDS, V13, pF123, DOI 10.1097/00002030-199912240-00001
  • [5] DUAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION AND RECOMBINATION IN A DUALLY EXPOSED TRANSFUSION RECIPIENT
    DIAZ, RS
    SABINO, EC
    MAYER, A
    MOSLEY, JW
    BUSCH, MP
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (06) : 3273 - 3281
  • [6] Synonymous-non-synonymous mutation rates between sequences containing ambiguous nucleotides (Syn-SCAN)
    Gonzales, MJ
    Dugan, JM
    Shafer, RW
    [J]. BIOINFORMATICS, 2002, 18 (06) : 886 - 887
  • [7] Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: Classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population
    Gonzales, MJ
    Machekano, RN
    Shafer, RW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (08) : 998 - 1006
  • [8] Antiretroviral drug resistance testing in adult HIV-1 infection -: Recommendations of an International AIDS Society-USA panel
    Hirsch, MS
    Brun-Vézinet, F
    D'Aquila, RT
    Hammer, SM
    Johnson, VA
    Kuritzkes, DR
    Loveday, C
    Mellors, JW
    Clotet, B
    Conway, B
    Demeter, LM
    Vella, S
    Jacobsen, DM
    Richman, DD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (18): : 2417 - 2426
  • [9] Human immunodeficiency virus type 1 population bottleneck during indinavir therapy causes a genetic drift in the env quasispecies
    Ibáñez, A
    Clotet, B
    Martínez, MA
    [J]. JOURNAL OF GENERAL VIROLOGY, 2000, 81 : 85 - 95
  • [10] Evolution of human immunodeficiency virus type 1 populations after resumption of therapy following interruption and shift in resistance genotype
    Izopet, J
    Souyris, C
    Hance, A
    Sandres-Sauné, K
    Alvarez, M
    Pasquier, C
    Clavel, F
    Puel, J
    Massip, P
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (10) : 1506 - 1510